ClinConnect ClinConnect Logo
Search / Trial NCT03519841

Performance Study of a Non-invasive Glucose Monitoring Device Prototype

Launched by RSP SYSTEMS A/S · May 8, 2018

Trial Information

Current as of July 21, 2025

Completed

Keywords

Non Invasive Glucose Monitoring Raman Spectroscopy

ClinConnect Summary

Protocol consists of two parts:

Part A) Subjects will collect spectral Raman data on device every 15 minutes for 10 hours a day for five days. The five days will be distributed within a timeframe of ten days. A Flash Glucose Monitor will be used as a comparator. In addition to this, four daily capillary Blood Glucose readings will be collected.

Part B) Subjects will perform four daily measuring sessions in which optical Raman readings are paired with capillary Blood Glucose comparator. Measuring sessions are performed in subjects' own home while maintaining usual diabetes management routi...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Male and female subjects 18 years of age or older
  • Diabetic patients (all types), insulin requiring
  • Skin phototype 1-4
  • Exclusion Criteria:
  • For female participants: Pregnancy or subject is attempting to conceive or not willing and able to practice birth control during the study duration
  • For female participants: Breastfeeding
  • Subjects not able to understand and read Danish
  • In Investigator's opinion, subject is not able to follow instructions as specified in the protocol
  • Rejection by optical screenings
  • Participants not able to hold hand/arm steadily (including tremors and Parkinson's Disease)
  • Diagnosed with reduced circulation
  • Extensive skin changes, tattoos or diseases on probe application site
  • Known allergy to medical grade alcohol
  • Known allergy to adhesives, applicable to subjects in RSP-13-01
  • Systemic or topical administration of glucocorticoids for the past 7 days
  • Subjects undergoing dialysis treatment
  • Medical history or any condition that may, in the opinion of the Investigator, compromise the subject's ability to participate
  • Concomitant medical condition which could present a risk to the safety or welfare of the subject or study staff.
  • Participants currently enrolled in another study

About Rsp Systems A/S

RSP Systems A/S is a leading clinical trial sponsor dedicated to advancing healthcare through innovative research and development. Specializing in the design and management of clinical trials, RSP Systems leverages cutting-edge technology and a robust infrastructure to facilitate efficient study execution. With a commitment to regulatory compliance and patient safety, the organization collaborates with healthcare professionals, research institutions, and industry partners to deliver high-quality data and insights that drive medical advancements. RSP Systems A/S is focused on enhancing therapeutic outcomes across various medical fields, ensuring that new treatments are developed responsibly and effectively.

Locations

Odense, , Denmark

Patients applied

0 patients applied

Trial Officials

Jan Erik Henriksen, MD, PhD

Principal Investigator

Steno Diabetes Center Odense, Denmark

Vibe Vestergaard, Nurse

Principal Investigator

Steno Diabetes Center Odense, Denmark

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials